Bharat Biotech Partners with Alopexx for Anti-Microbial Vaccine

By By Rediff Money Desk, Hyderabad
Sep 11, 2024 14:14
Bharat Biotech and Alopexx collaborate to develop and commercialize a broad-spectrum anti-microbial vaccine, AV0328, in India and other low-income countries. The vaccine targets poly N-acetyl glucosamine (PNAG) and aims to combat antimicrobial resistance.
Hyderabad, Sep 11 (PTI) Bharat Biotech on Wednesday announced a collaboration with Alopexx, Inc. for the co-development and commercialisation of the latter's proprietary broad-spectrum anti-microbial vaccine, AV0328, in India and other low income and lower middle-income countries.

A press release from the city-based vaccine maker said as part of the collaboration, the companies will co-develop and commercialise AV0328, a synthetic vaccine targeting poly N-acetyl glucosamine (PNAG), in India and other licensed territories.

Alopexx would be entitled to a one-time upfront payment and milestone payments, as well as royalties on future sales of AV0328 in the licensed territories, it said.

Krishna Ella, Executive Chairman of Bharat Biotech, said, "We are proud to collaborate with Alopexx to bring AV0328 to the regions where it is most needed. Our goal is to develop solutions to reduce anti-microbial resistance through vaccination. This collaboration aligns with our mission to provide safe, affordable, and high-quality vaccines to combat infectious diseases globally."

"This collaboration brings us one step closer to addressing the critical need for affordable, broad-spectrum antimicrobial solutions, especially in low-and middle-income countries," Daniel Vlock, CEO of Alopexx, said.
Source: PTI
Read More On:
indiacollaborationbharat biotechvaccine developmentantimicrobial resistancelow-income countriesalopexxav0328antimicrobial vaccinepnag
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

Sebi Approves IPOs for Schloss Bangalore, Ather...

Sebi has approved IPO proposals from six companies, including Schloss Bangalore, Ather...

McDonald's Opens First Restaurant in Sikkim,...

McDonald's has opened its first restaurant in Gangtok, Sikkim, marking its entry into...

Bullion Rates Today: Gold, Silver Prices in...

Get the latest bullion rates for gold and silver in Bengaluru. Check today's prices for...

Wheat Sowing Area Up 2.15%, Oilseeds Decline -...

Wheat acreage rose 2.15% in India's ongoing rabi season, while oilseeds acreage fell...

SAIL Wins 'Great Place to Work' Certification...

State-owned SAIL has been certified as a 'Great Place to Work' for the second...

Banks to Offer Beneficiary Name Lookup in NEFT,...

RBI mandates banks to provide beneficiary account name verification facility for NEFT &...

Honey Export Price Extended to Dec 2025

India extends minimum export price for honey till Dec 2025, aiming to protect domestic...

India Aims for $1 Billion Banana Exports to Russia

India targets Russia to boost banana exports to USD 1 billion, utilizing sea routes for...

Cyber Frauds & Mule Accounts: RBI Warns of...

The Reserve Bank of India (RBI) warns of increasing cyber fraud and the need to...

Vinsys Expands to Saudi Arabia: 6th Middle East...

Vinsys IT Services opens its second office in Saudi Arabia, expanding its presence in...

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com